Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: trial reanalysis adjusted for baseline imbalances

OBJECTIVES: Alteplase is commonly recommended for acute ischaemic stroke within 4.5 hours after stroke onset. The Third European Cooperative Acute Stroke Study (ECASS III) is the only trial reporting statistically significant efficacy for clinical outcomes for alteplase use 3–4.5 hours after stroke...

Descripción completa

Detalles Bibliográficos
Autores principales: Alper, Brian Scott, Foster, Gary, Thabane, Lehana, Rae-Grant, Alex, Malone-Moses, Meghan, Manheimer, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548536/
https://www.ncbi.nlm.nih.gov/pubmed/32430395
http://dx.doi.org/10.1136/bmjebm-2020-111386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548536/
https://www.ncbi.nlm.nih.gov/pubmed/32430395
http://dx.doi.org/10.1136/bmjebm-2020-111386

Ejemplares similares